Corrigendum to “Comparison of dalbavancin with standard of care in the management of infective endocarditis: efficacy, safety, and cost analysis” [International Journal of Infectious Diseases, Volume 138 (January 2024), Pages 41-45]
- DOI
- 10.1016/j.ijid.2026.108901
- Published
- 2026-09
- Container
- International Journal of Infectious Diseases
- Publisher
- Elsevier BV
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1016/j.ijid.2026.108901,
title = {Corrigendum to “Comparison of dalbavancin with standard of care in the management of infective endocarditis: efficacy, safety, and cost analysis” [International Journal of Infectious Diseases, Volume 138 (January 2024), Pages 41-45]},
author = {M. Suárez and A. Pérez-Landeiro and A. Sanjurjo and O. Lima and A. Sousa and A. López and L. Martínez-Lamas and X. Cabrera and M. Rubianes and M.T. Pérez-Rodríguez},
year = {2026},
journal = {International Journal of Infectious Diseases},
doi = {10.1016/j.ijid.2026.108901},
url = {https://doi.org/10.1016/j.ijid.2026.108901}
}RIS
TY - JOUR TI - Corrigendum to “Comparison of dalbavancin with standard of care in the management of infective endocarditis: efficacy, safety, and cost analysis” [International Journal of Infectious Diseases, Volume 138 (January 2024), Pages 41-45] AU - M. Suárez AU - A. Pérez-Landeiro AU - A. Sanjurjo AU - O. Lima AU - A. Sousa AU - A. López AU - L. Martínez-Lamas AU - X. Cabrera AU - M. Rubianes AU - M.T. Pérez-Rodríguez PY - 2026 JO - International Journal of Infectious Diseases DO - 10.1016/j.ijid.2026.108901 UR - https://doi.org/10.1016/j.ijid.2026.108901 ER -
APA
Suárez, M., Pérez-Landeiro, A., Sanjurjo, A., Lima, O., Sousa, A., López, A., Martínez-Lamas, L., Cabrera, X., Rubianes, M., & Pérez-Rodríguez, M. (2026). Corrigendum to “Comparison of dalbavancin with standard of care in the management of infective endocarditis: efficacy, safety, and cost analysis” [International Journal of Infectious Diseases, Volume 138 (January 2024), Pages 41-45]. International Journal of Infectious Diseases. https://doi.org/10.1016/j.ijid.2026.108901
Source records
- crossref · retrieved 2026-09-26T03:22:33.424Z